Cargando…
Engineered drug-loaded cellular membrane nanovesicles for efficient treatment of postsurgical cancer recurrence and metastasis
Cancer recurrence and metastasis are still common causes of postsurgery death in patients with solid tumors, suggesting that additional consolidation therapeutic strategies are necessary. We have previously found that oxaliplatin (OXA) treatment causes further up-regulation of CD155, which is abunda...
Autores principales: | Yu, Yongkang, Cheng, Qinzhen, Ji, Xiaoyuan, Chen, Hongzhong, Zeng, Wenfeng, Zeng, Xiaowei, Zhao, Yanli, Mei, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733928/ https://www.ncbi.nlm.nih.gov/pubmed/36490349 http://dx.doi.org/10.1126/sciadv.add3599 |
Ejemplares similares
-
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
por: Cheng, Qinzhen, et al.
Publicado: (2023) -
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
por: Rao, Lang, et al.
Publicado: (2020) -
Portable air-fed cold atmospheric plasma device for postsurgical cancer treatment
por: Chen, Guojun, et al.
Publicado: (2021) -
Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances
por: Zhang, Endong, et al.
Publicado: (2023) -
Engineering high‐affinity dual targeting cellular nanovesicles for optimised cancer immunotherapy
por: Zhang, Luyao, et al.
Publicado: (2023)